Japanese Pharma Must Face Antitrust Action Courthouse News Service A group of consumers who bought Prograf, Astellas' brand-name version of the immunosuppressant drug tacrolimus, claims the company filed a "sham" petition to the Food and Drug Administration to try to halt the approval of a generic version - and raked ... |
